Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zajonc

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
Plos One|December 7, 2013
Helicobacter pylori cholesteryl α-glucosides contribute to its pathogenicity and immune response by natural killer T cellsYuki Ito, Jose Luis Vela, Fumiko Matsumura, et al.
Molecular Immunology|February 3, 2009
Functional CD1d and/or NKT cell invariant chain transcript in horse, pig, African elephant and guinea pig, but not in ruminantsFrank A Looringh van Beeck, Peter Reinink, Roel Hermsen, et al.
The Journal of Biological Chemistry|November 11, 2017
Structure-function characterization of three human antibodies targeting the vaccinia virus adhesion molecule D8Michael H Matho, Andrew Schlossman, Iuliia M Gilchuk, et al.
Cell Host & Microbe|March 19, 2013
Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defensesWendell Smith, Peter Tomasec, Rebecca Aicheler, et al.
Cell Death and Differentiation|February 11, 2017
N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced deathFlorent Dufour, Thibault Rattier, Sarah Shirley, et al.
Nature Immunology|August 22, 2006
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteriaYuki Kinjo, Emmanuel Tupin, Douglass Wu, et al.
Nature Immunology|October 23, 2019
Control of CD1d-restricted antigen presentation and inflammation by sphingomyelinEspen Melum, Xiaojun Jiang, Kristi D Baker, et al.
Nature Immunology|September 6, 2011
Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteriaYuki Kinjo, Petr Illarionov, José Luis Vela, et al.
The EMBO Journal|December 3, 2009
Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligandsWilliam C Florence, Chengfeng Xia, Laura E Gordy, et al.
The EMBO Journal|October 10, 2009
Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligandsWilliam C Florence, Chengfeng Xia, Laura E Gordy, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
Plos One|December 7, 2013
Helicobacter pylori cholesteryl α-glucosides contribute to its pathogenicity and immune response by natural killer T cellsYuki Ito, Jose Luis Vela, Fumiko Matsumura, et al.
Molecular Immunology|February 3, 2009
Functional CD1d and/or NKT cell invariant chain transcript in horse, pig, African elephant and guinea pig, but not in ruminantsFrank A Looringh van Beeck, Peter Reinink, Roel Hermsen, et al.
The Journal of Biological Chemistry|November 11, 2017
Structure-function characterization of three human antibodies targeting the vaccinia virus adhesion molecule D8Michael H Matho, Andrew Schlossman, Iuliia M Gilchuk, et al.
Cell Host & Microbe|March 19, 2013
Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defensesWendell Smith, Peter Tomasec, Rebecca Aicheler, et al.
Cell Death and Differentiation|February 11, 2017
N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced deathFlorent Dufour, Thibault Rattier, Sarah Shirley, et al.
Nature Immunology|August 22, 2006
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteriaYuki Kinjo, Emmanuel Tupin, Douglass Wu, et al.
Nature Immunology|October 23, 2019
Control of CD1d-restricted antigen presentation and inflammation by sphingomyelinEspen Melum, Xiaojun Jiang, Kristi D Baker, et al.
Nature Immunology|September 6, 2011
Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteriaYuki Kinjo, Petr Illarionov, José Luis Vela, et al.
The EMBO Journal|December 3, 2009
Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligandsWilliam C Florence, Chengfeng Xia, Laura E Gordy, et al.
The EMBO Journal|October 10, 2009
Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligandsWilliam C Florence, Chengfeng Xia, Laura E Gordy, et al.
Pageof 17